Healthcare Analyst

Wilfred Yuen

Healthcare analyst with 12+ years’ experience in both sell-side and buy-side leadership roles, with extensive experience IPO experience and a robust network of institutional investors and corporate executives. Coverage spans biopharma, biotech, CROs, devices, and health-tech stocks, delivered through with stock/sector/thematic reports, detailed financial models, and direct corporate access.

Iambic Tx IPO First-Read: AI Models Enchant/NeuralPLexer, IAM1363 (Type II HER2i), Partnerships

China Healthcare Weekly Wrap (28 Sep - 2 Oct)

Genscript (1548.HK): 1H26 Results Driven by AI Orders; Guidance Upgrades on Life-Science and Probio

Key Takeaways from WCLC 2026: Akeso/SMMT, Hansoh/GSK, MediLink/Roche, RemeGen/AbbVie...

China Healthcare Weekly Wrap (31 Aug - 4 Sep)

Thematic (Sector/Industry)

China Health care / Thematic (Sector/Industry)

<ul>
<li>For World Lung Cancer Conference (WCLC 2026), we wrap-up key data updates, covering drugs from Akeso/SMMT, Hansoh/GSK, MediLink/Roche, RemeGen/AbbVie, Leads Biolabs, GenFleet, CSPC, Hengrui, and Henlius
</li>
<li>AI drugs news flow: 1) Lilly Tunelab announced agreements with Genscript, Twist, Gingko; 2) Harbour Bio developed world's first language model for heavy-chains-only antibodies; 3) ByteDance's Anew Labs raised US$290m</li>
<li>Other updates include LEGN's new CEO appointment, Chimagen/GSK licensing deal, China's 5-year plan for pharmaceutical industry</li>
</ul>


For World Lung Cancer Conference (WCLC 2026), we wrap-up key data updates, covering drugs from Akeso/SMMT, Hansoh/GSK, MediLink/Roche, RemeGen/AbbVie, Leads Biolabs, GenFleet, CSPC, Hengrui, and Henlius

AI drugs news flow: 1) Lilly Tunelab announced agreements with Genscript, Twist, Gingko; 2) Harbour Bio developed world's first language model for heavy-chains-only antibodies; 3) ByteDance's Anew Labs raised US$290m
Other updates include LEGN's new CEO appointment, Chimagen/GSK licensing deal, China's 5-year plan for pharmaceutical industry


China Healthcare Weekly Wrap (14-18 Sep)